KEYNOTE024_2: KEYNOTE024, figure 2

KEYNOTE024_2R Documentation

KEYNOTE024, figure 2

Description

Kaplan-Meier digitized data from KEYNOTE024, figure 2 (PMID 27718847). A reported sample size of 305 for a primary endpoint of PFS in lung cancer.

Usage

KEYNOTE024_2

Format

A data frame of 305 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (chemo, pembrolizumab)

Source

Reck M, Rodríguez-Abreu D, Robinson AG, et al. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. N Engl J Med 2016; 375: 1823–33.

Examples

summary(KEYNOTE024_2)

kmplot(KEYNOTE024_2)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.